SCHEMBL5458670

SCHEMBL5458670

CC(=O)c1c(-c2ccc(Br)cc2)nn2c(Cl)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
HTT P42858 2/20 0.41
CSF1R P07333 1/20 0.36
FGFR1 P11362 1/20 0.36
FLT1 P17948 1/20 0.36
KDR P35968 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK8 P49336 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
PRKCQ Q04759 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14592091 0.88 CSF1R (0.47) MAPK14NPSR1CSF1RFGFR1FLT1
SCHEMBL6106523 0.87 ALDH1A1 (0.41) MAPK14MAPTNPSR1HTTCSF1R
SCHEMBL5453011 0.87 MAPK14 (0.56) MAPK14CSF1RFGFR1FLT1KDR
SCHEMBL5212963 0.85 MAPK14 (0.54) MAPK14MAPTHTTCSF1RFGFR1
SCHEMBL5457446 0.85 MAPK14 (0.36) MAPK14CSF1RFGFR1FLT1KDR
SCHEMBL6105823 0.85 ALDH1A1 (0.43) MAPK14MAPTAURKARAB9AKDM4E
SCHEMBL6107287 0.81 ALDH1A1 (0.38) MAPK14MAPTRORCRAB9AKDM4E
SCHEMBL6107099 0.81 PABPC1 (0.34) MAPK14CSF1RFGFR1FLT1KDR
SCHEMBL5208943 0.80 FYN (0.41) MAPK14MAPTNPSR1CDK5DYRK1B
SCHEMBL5462814 0.76 HDAC3 (0.38) MAPTNPSR1HTTRXFP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287721-A1 Pyrazolopyridinyl pyridine BOYD F LESLIE 2007-12-13 US disclosed
US-7153855-B2 Pyrazolopyridinyl pyrimidine therapeutic compounds SMITHKLINE BEECHAM CORPORATION (US) 2006-12-26 US disclosed
EP-1377573-B1 PYRAZOLOPYRIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2005-07-27 EP disclosed
US-20050049260-A1 Therapeutic compounds SMITHKLINE BEECHAM CORPORATION 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287721-A1 Pyrazolopyridinyl pyridine CYP3A5, CYP2C19, CYP3A4 MAPK14 2533/4885MAPT 1659/4885NPSR1 2209/4885
US-20050049260-A1 Therapeutic compounds ABCB1, PCSK9, ABCB11 MAPK14 4328/4885MAPT 696/4885NPSR1 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.